Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
  1. 4 Grant or award President and CEO acquired 1,979,346 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $7.38 ($36,900)
  8. 4 Open-market buy Director bought 5,000 shares at $7.37 ($36,850)
  9. 4 Open-market buy Chief Financial Officer bought 4,545 shares at $7.90 ($35,906)
  10. 4 Open-market buy Chairman and CEO bought 10,000 shares at $7.59 ($75,900)
  11. 4 Open-market buy Director bought 10,000 shares at $7.62 ($76,231)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy SVP & Chief Accounting Officer bought 1,503 shares at $3.88 ($5,832)
  15. 4 Open-market buy Chief Financial Officer bought 4,979 shares at $3.88 ($19,319)
  16. 4 Open-market buy Executive VP and COO bought 5,000 shares at $3.88 ($19,400)
  17. 4 Gift President gave 3,000 shares (gift)
  18. 4/A Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 15 · 291 filings